4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000120
General Counsel sold 9,000 shares at an average $94.89 ($853,986)
- General Counsel acquired 9,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Quinlan Paul T · General Counsel
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-20 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,000 | $7.80 | $70,200 | 38,995 | D |
| 2026-11-20 | Sale : show line 2 in the form 10b5-1 | −3,300 | $94.05 | $310,360 | 35,695 | D |
| 2026-11-20 | Sale : show line 3 in the form 10b5-1 | −3,000 | $94.77 | $284,320 | 32,695 | D |
| 2026-11-20 | Sale : show line 4 in the form 10b5-1 | −2,500 | $95.99 | $239,986 | 30,195 | D |
| 2026-11-20 | Sale : show line 5 in the form 10b5-1 | −200 | $96.60 | $19,320 | 29,995 | D |
| Open-market sales · 9,000 sh · avg $94.89 · $853,986 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2026-11-20 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Warrant (right to buy) | −9,000 | $7.80 | 2034-07-14 | 9,000 | 61,996 | D |
Loading xslF345X06/form4.xml…